A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type β-lactamases

35Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A TEM-1 β-lactamase derivative containing the single amino acid substitution A237T slightly increased (from 24 to 32 μg/ml) the cephalothin MIC for Escherichia coli RYC1000 but did not influence the activities of cefotaxime, ceftazidime, and aztreonam (MICs of 0.03, 0.12, and 0.06 μg/ml, respectively). Despite its apparent neutrality, addition of the A237T mutation to the pair of mutations characterizing TEM-10 (R164S and E240K) had a strong effect on substrate preference. Ceflazidime and aztreonam MICs decreased from 128 and 16 μg/ml to 16 and 2 μg/ml, respectively. In contrast, the cefotaxime MIC increased from 0.5 to 4 μg/ml. The acquisition of apparently neutral or even deleterious mutations results in a very effective mechanism of resistance to different β-lactams that may be simultaneously or subsequently present in the environment. We propose here that the mutation in position 237 is an example of a modulating mutation and that consideration of this type of mutation may be important for understanding the evolution of β-lactamases.

Cite

CITATION STYLE

APA

Blázquez, J., Negri, M. C., Morosini, M. I., Gómez-Gómez, J. M., & Baquero, F. (1998). A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type β-lactamases. Antimicrobial Agents and Chemotherapy, 42(5), 1042–1044. https://doi.org/10.1128/aac.42.5.1042

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free